Sponsored: Is your retirement plan actually built to last? Take a 20-second quiz to book a call with Kyle and Dane at DePaolo & May Strategic Wealth. They’ll give you an honest opinion on whether you’re on track. Click here to take the quiz and book a call.

The damage this morning is concentrated on the downside, and it is not one story. A retailer told investors its customers are showing up less, a beauty name told them the turnaround needs another year, and a chipmaker missed by a hair and got treated like it missed by a mile. Three double-digit drops, three different ways to disappoint.

The gainers are quieter and more forgiving. A policy headline is doing the work in one corner of the market, and one industrial simply raised its outlook, which is rare enough right now to get paid for.

Most portfolios are a pile of accounts, not a plan. DePaolo & May — a fee-only, fiduciary firm named a Top 25 Rising Star advisory firm by USA Today — will review your situation and tell you honestly if you're on track.

Strategy (MSTR): +5%

Bitcoin and ether ripped higher after President Trump pushed Congress to pass crypto-friendly legislation, and the leveraged equity proxies moved hardest. Strategy is the purest stock-market expression of that trade, which is why it outran every other crypto-linked name in premarket. When Washington starts sounding constructive, the balance sheet bet gets repriced first.

Nordson (NDSN): +4%

The maker of coating and adhesive application equipment raised its full-year earnings outlook, and the new range landed above where the street was already carrying it. Guidance raises out of industrial names are scarce enough right now that the market reads them as a signal on end-market demand, not just company execution.

Advance Auto Parts (AAP): -20%

Second quarter results came in mixed, with revenue falling well short of expectations and comparable sales going negative when analysts were modeling growth. Earnings per share actually topped the bar, but a comp decline in a business built on non-discretionary demand is the number that matters. That reads as a traffic problem, not a margin problem.

Moderna (MRNA): -16%

The stock is handing back a slice of yesterday's 177% surge on cancer vaccine data. Nothing about the trial changed overnight: the experimental vaccine, developed with Merck (MRK) and paired with Keytruda, hit its goals in higher-risk and advanced melanoma patients whose tumors had been surgically removed. This is what profit-taking looks like after a move that size.

Coty (COTY): -13%

The beauty company's quarterly loss came in wider than analysts expected, and revenue beat, but neither figure drove the reaction. Management calling fiscal 2027 a transition year did. Investors are saying plainly that they will not underwrite a turnaround that just got pushed out another twelve months.

Wolfspeed (WOLF): -6%

Quarterly revenue landed just under consensus, and that narrow miss was enough to take the semiconductor components maker down double digits. Its loss per share was actually smaller than analysts expected, which tells you the market is grading this name on demand, not on cost control.

Most portfolios are a pile of accounts, not a plan. DePaolo & May — a fee-only, fiduciary firm named a Top 25 Rising Star advisory firm by USA Today — will review your situation and tell you honestly if you're on track.

Hertz Global Holdings (HTZ)

Hertz has spent two weeks as one of the most-mentioned tickers on r/wallstreetbets, and the pitch circulating there is almost entirely mechanical: an extremely high short interest percentage against a low share price, with traders trading the squeeze setup rather than the business. Mentions were still climbing into this morning even without a fresh catalyst on the tape.

The counterweight is substantial. Pershing Square fully exited its position, the stock was removed from the S&P SmallCap 600 in early August, Susquehanna cut its price target to $2.50 while holding a Neutral rating, and multiple securities class actions are working through the courts with a September lead-plaintiff deadline. Whether retail attention can hold a name carrying that much structural pressure is the thing worth watching, not predicting.

✌️That’s it for today.